News & Events


Troponin I and NT-proBNP now KFDA (MFDS) approved!

The Korean Ministry of Food and Drug Safety (KFDA) has approved Exdia Troponin I and Exdia NT-proBNP, our reagents for cardiac symptoms, this July.


Following the acquisition of KFDA (MFDS) approval of Exdia PCT, Exdia iFOB, and Exdia β-hCG in the first half of the year, and the continuous approval of Exdia Troponin I and Exdia NT-proBNP this July, Precision Biosensor is now working to gain the KFDA (MFDS) approval of Exdia D-Dimer, Exdia 3-in-1 (TnI, Myo, CK-MB), and Exdia Influenza A+B until end of this year.


With the continuous success in acquiring the KDFA (MFDS) approval, Precision Biosensor has enhanced the distribution lineup of products in Korea and many other countries that requires KFDA (MFDS) registration.